MONOVISC for Ankle Joint Pain Relief Due to Osteoarthritis
A Prospective Study of a Single Injection Cross-linked Sodium Hyaluronate (MONOVISC) to Provide Symptomatic Relief of Osteoarthritis of Ankle Joint
Sponsor: Anika Therapeutics, Inc.
This NA trial investigates Osteoarthritis Ankle and is currently completed. Anika Therapeutics, Inc. leads this study, which shows 8 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Feb 2025 — Sep 2025 [monthly]
Completed NA
-
Sep 2024 — Feb 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2021 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 3 earlier versions
-
Feb 2021 — May 2021 [monthly]
Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Recruiting NA
-
Jan 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Dec 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Anika Therapeutics, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .